I am extremely thankful that there are two Covid clinical trials covering the spectrum from mild to severe conditions, otherwise it would be another long wait till the FSGS interim results.
I still wonder if the CKD results will be mimicked in the REMAP-CAP, moderate to severe group than the CLARITY 2 mild group.
Then of course, there’s the group that have been on the drug for years, with special access.
Can’t wait for Xmas.
cheers
DXB Chart, page-116
-
- There are more pages in this discussion • 1,005 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
47.0¢ |
Change
-0.055(10.5%) |
Mkt cap ! $258.5M | |||
| Open | High | Low | Value | Volume |
| 52.0¢ | 52.0¢ | 46.0¢ | $3.239M | 6.664M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 560016 | 46.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 47.0¢ | 157751 | 4 |
View Market Depth
| Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
| DXB (ASX) Chart |